PTC Therapeutics Inc (PTCT)
$35.10 -$0.27 (-0.76%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.89B -
Day's Range
$35.00 - $36.28 -
Volume
754,003 -
52 Week Low / High
$17.53 - $40.69 -
PE Ratio
- -
PEG Ratio
0.81 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 6
- Strong Buy
- 1
- Buy
- 5
- Hold
- 2
- Sell
- 1
- Strong Sell
- $35.42
- Target Price
Company News
-
FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program — Sep 26th, 2024
WARREN, N.J., Sept. 26, 2024 /PRNewswire/ -- PTC Therapeutics (NASDAQ: PTCT) announced today that the FDA has granted Fast Track designation to the PTC518 program for the treatment of Huntington's disease. Fast Track designation is awarded to promising therapies for diseases of high unmet ...
-
PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients — Oct 1st, 2024
WARREN, N.J., Oct. 1, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the FDA has accepted for filing the New Drug Application (NDA) of sepiapterin for the treatment of pediatric and adult patients living with phenylketonuria (PKU). A Prescription Drug User Fee A...
Similar Stocks
Portfolio
Comprised of 1 portfolios